20 articles
Researchers used retinal imaging to detect brain amyloid and tested whether telomerase activation could reduce Alzheimer's markers.
A completed Phase 2 trial tests UCPVax cancer vaccine combined with atezolizumab in cervical, anal, and head-and-neck cancers.
A Phase 4 trial tests whether simplifying HIV treatment to two drugs worsens hidden viral replication and immune dysfunction.
Phase 1 trial examines whether vesatolimod can safely stimulate immune response in HIV controllers during treatment interruption.
Researchers explored whether cancer-derived cell-free DNA and telomere maintenance mutations could serve as early warning biomarkers in soft tissue sarcoma patients.
Researchers analyzed epigenetic changes in 124 Israeli centenarians to understand the molecular basis of exceptional longevity.
67-person study tested whether whole foods diet and stress reduction could lengthen protective chromosome caps in pain sufferers.
A phase 1/2 trial combined mocetinostat and durvalumab in 83 patients with advanced solid tumors and NSCLC.
Scientists modified patients' immune cells to better recognize and attack cancer tumors expressing NY-ESO-1 protein.
Study examines whether CPAP therapy for sleep apnea can prevent telomere shortening and reduce cellular aging markers.
FDA-approved transplant drug tested in 70-95 year olds to combat age-related immune decline and improve longevity markers.
Chinese researchers tested nucleotide supplements against aging markers in 122 participants over 4 months with promising early results.
Phase 2 trial explores whether combining oncolytic virus therapy with immunotherapy can rescue patients whose melanoma progressed on PD-1 blockade.
French study reveals how diabetes triggers premature cellular aging that may lead to dangerous heart muscle weakening.
A French trial investigated whether circulating immune cell profiles, specifically CD226 expression, could predict who responds to Atezolizumab/Bevacizumab in advanced HCC.
DuoStim lets women with poor ovarian reserve collect more eggs in one cycle, potentially cutting time to a successful pregnancy.
Six-month trial examines whether metformin treatment can improve telomere length and longevity gene expression in prediabetic individuals.
UCSF study tests whether stress-reduction classes can reverse biological markers of cellular aging in overwhelmed caregivers.
Engineered immune cells target liver cancer protein in phase I safety study, though trial ended early with 10 patients.
Small trial tests whether rapamycin, an FDA-approved drug, can improve heart function and immune response in people aged 70-95.
